Baird Extends HealthEquity (HQY) Residency on Fresh Pick List

Baird Extends HealthEquity (NASDAQ: HQY) Residency on Fresh Pick List.

Analyst Mark Marcon comments "We are extending our Bullish Fresh Pick on HealthEquity (HQY) following thisweek's FOMC meeting which indicated a Fed funds rate of 5.1% in 2023 followed by4.1% in 2024. We are extending our Bullish Fresh Pick through March 24 which isright after HQY posts FQ4 results which we believe will be positive. HQY is leveredto higher rates which will benefit earnings over the next few years (particularly ifrates remain elevated). HQY could further benefit as PMs seek some diversification/positive exposure to higher rates."

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Dollarama Inc. (DOL:CN) (DLMAF) PT Raised to Cdn$221 at BMO Capital
• Citi upgrades AMD to buy with $575 price target ahead of Q4 earnings